Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

被引：0
|
作者：
Laura G. Estevez
José Luis Fortes
Encarna Adrover
Gloria Peiró
Mireia Margelí
Eva Castellá
José Miguel Cuevas
Laia Bernet
Miguel Angel Segui
Xavier Andreu
机构：
[1] Fundación Jiménez Díaz,
[2] Hospital General Universitario de Alicante,undefined
[3] Hospital Universitario Germans Trias i Pujol,undefined
[4] Hospital de la Ribera,undefined
[5] Consorci Hospitalari Parc Tauli,undefined
[6] GEICAM Cooperative,undefined
来源：
Clinical and Translational Oncology | 2009年 / 11卷
关键词：
Anthracycline; Breast carcinoma; Primary chemotherapy; Sequential; Taxane; Weekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：54 / 59
页数：5
相关论文
共 50 条
  • [41] Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Nabholtz, JM
    Mackey, JR
    Smylie, M
    Paterson, A
    Noël, DR
    Al-Tweigeri, T
    Tonkin, K
    North, S
    Azli, N
    Riva, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 314 - 321
  • [42] Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: Results of a feasibility study
    Cardoso, F
    Ferreira, AF
    Crown, J
    Dolci, S
    Paesmans, M
    Riva, A
    Di Leo, A
    Piccart, MJ
    [J]. ANTICANCER RESEARCH, 2001, 21 (1B) : 789 - 795
  • [43] Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer
    Montero, A. J.
    Diaz-Montero, C. M.
    Deutsch, Y. E.
    Hurley, J.
    Koniaris, L. G.
    Rumboldt, T.
    Yasir, S.
    Jorda, M.
    Garret-Mayer, E.
    Avisar, E.
    Slingerland, J.
    Silva, O.
    Welsh, C.
    Schuhwerk, K.
    Seo, P.
    Pegram, M. D.
    Glueck, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 215 - 223
  • [44] Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer
    Grazia, Artioli
    Simone, Mocellin
    Lucia, Borgato
    Alessandro, Cappetta
    Fernando, Bozza
    Giorgio, Zavagno
    Stefania, Zovato
    Alberto, Marchet
    Davide, Pastorelli
    [J]. ANTICANCER RESEARCH, 2010, 30 (09) : 3817 - 3821
  • [45] S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
    Yong Wha Moon
    Soohyeon Lee
    Byeong-Woo Park
    Eun-Kyung Kim
    Seung Il Kim
    Ja Seung Koo
    Seho Park
    Min Jung Kim
    Hyun Cheol Chung
    Joo-Hang Kim
    Joohyuk Sohn
    [J]. BMC Cancer, 13
  • [46] Use of Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy for Breast Cancer
    Livi, L.
    Meattini, I.
    Cardillo, C. De Luca
    Scotti, V.
    Agresti, B.
    Franzese, C.
    Sanchez, L.
    Nori, J.
    Bertocci, S.
    Cassani, S.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    [J]. JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 36 - 39
  • [47] S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
    Moon, Yong Wha
    Lee, Soohyeon
    Park, Byeong-Woo
    Kim, Eun-Kyung
    Kim, Seung Il
    Koo, Ja Seung
    Park, Seho
    Kim, Min Jung
    Chung, Hyun Cheol
    Kim, Joo-Hang
    Sohn, Joohyuk
    [J]. BMC CANCER, 2013, 13 : 1 - 7
  • [48] Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer
    Wenzel, C
    Locker, GJ
    Pluschnig, U
    Zielinski, CC
    Rudas, M
    Oberhuber, G
    Gnant, MF
    Taucher, S
    Jakesz, R
    Steger, GG
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 155 - 159
  • [49] Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer
    Catharina Wenzel
    Gottfried J. Locker
    Ursula Pluschnig
    Christoph C. Zielinski
    Margarethe Rudas
    Gerhard Oberhuber
    Michael F. Gnant
    Susanne Taucher
    Raimund Jakesz
    Guenther G. Steger
    [J]. Cancer Chemotherapy and Pharmacology, 2002, 50 : 155 - 159
  • [50] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
12345